Search Results - "El Chediak, Alissar"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Role of Ultrastructural Study in the Diagnosis of Medical Renal Diseases: A Tertiary Medical Center Experience and Review of the Literature by Chediak, Alissar El, Tawil, Ayman, Farroukh, Lea, Farhat, Hadi, Kassouf, Hala

    “…The 20 th century unfolded many mysteries regarding renal pathology with the advent of ancillary techniques such as immunofluorescence (IF) and electron…”
    Get full text
    Journal Article
  2. 2

    Bile cast nephropathy: when the kidneys turn yellow by El Chediak, Alissar, Janom, Khaled, Koubar, Sahar H.

    Published in Renal replacement therapy (17-03-2020)
    “…Abstract Kidney injury is a common finding in patients with liver disease. Bile cast nephropathy (also known as cholemic nephropathy) is an overlooked cause of…”
    Get full text
    Journal Article
  3. 3

    Increase in spleen volume as a predictor of oxaliplatin toxicity by El Chediak, Alissar, Haydar, Ali A, Hakim, Ayman, Massih, Sarah Abdel, Hilal, Lara, Mukherji, Deborah, Temraz, Sally, Shamseddine, Ali

    Published in Therapeutics and clinical risk management (01-01-2018)
    “…Oxaliplatin is a nonconventional third-generation platinum compound. It is an important chemotherapeutic agent in regimens used in gastrointestinal carcinomas…”
    Get full text
    Journal Article
  4. 4

    Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort by El Chediak, Alissar, Alameddine, Raafat S, Hakim, Ayman, Hilal, Lara, Abdel Massih, Sarah, Hamieh, Lana, Mukherji, Deborah, Temraz, Sally, Charafeddine, Maya, Shamseddine, Ali

    Published in Breast cancer targets and therapy (01-01-2017)
    “…Several retrospective studies have reported that younger age at presentation is associated with a worse prognosis for nonmetastatic breast cancer patients. In…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients by Sarrell, Bonnie Ann, Bloch, Karen, El Chediak, Alissar, Kumm, Kayla, Tracy, Kaitlyn, Forbes, Rachel C., Langone, Anthony, Thomas, Lora, Schlendorf, Kelly, Trindade, Anil J., Perri, Roman, Wright, Patty, Concepcion, Beatrice P.

    Published in Transplant infectious disease (01-02-2022)
    “…Solid organ transplant (SOT) recipients are at high risk for severe coronavirus disease 2019 (COVID‐19). Studies suggest that early intervention with…”
    Get full text
    Journal Article
  7. 7

    SuPAR, an emerging biomarker in kidney and inflammatory diseases by Hamie, Lamiaa, Daoud, Georges, Nemer, Georges, Nammour, Tarek, El Chediak, Alissar, Uthman, Imad W, Kibbi, Abdul Ghani, Eid, Assaad, Kurban, Mazen

    Published in Postgraduate medical journal (01-09-2018)
    “…Soluble urokinase plasminogen activator receptor (suPAR) is a circulating form of a physiological and pathophysiological important cell surface receptor,…”
    Get full text
    Journal Article
  8. 8

    Disseminated Nocardiosis in Kidney Transplant Recipients: A Report of 2 Cases by El Chediak, Alissar, Triozzi, Jefferson L., Schaefer, Heidi, Shawar, Saed

    Published in Kidney medicine (01-12-2022)
    “…Nocardiosis is a rare, life-threatening opportunistic infection caused by bacteria in the environment that predominantly affects immunocompromised patients…”
    Get full text
    Journal Article
  9. 9

    Genitourinary Interventions in Autosomal Dominant Polycystic Kidney Disease: Clinical Recommendations for Urologic and Transplant Surgeons by El Chediak, Alissar, Degheili, Jad A, Khauli, Raja B

    Published in Experimental and clinical transplantation (01-02-2021)
    “…Autosomal dominant polycystic kidney disease is the fourth most common single cause of end-stage renal disease worldwide with both renal and extrarenal…”
    Get full text
    Journal Article
  10. 10

    Primary synovial sarcoma of the kidney: a case report of complete pathological response at a Lebanese tertiary care center by El Chediak, Alissar, Mukherji, Deborah, Temraz, Sally, Nassif, Samer, Sinno, Sara, Mahfouz, Rami, Shamseddine, Ali

    Published in BMC urology (11-05-2018)
    “…Primary synovial sarcoma of the kidney is a rare type of soft tissue sarcoma. Its presenting features can resemble those of other renal tumors; rendering its…”
    Get full text
    Journal Article
  11. 11

    Severe ketoacidosis in a patient with spinal muscular atrophy by Lakkis, Bassel, El Chediak, Alissar, Hashash, Jana G., Koubar, Sahar H.

    Published in CEN case reports (01-11-2018)
    “…Spinal muscular atrophy (SMA) is a genetic neuromuscular disease characterized by progressive muscle weakness and atrophy. We report a case of a 36-year-old…”
    Get full text
    Journal Article
  12. 12

    Pancreaticoduodenal Artery Aneurysm Associated with Celiac Trunk Stenosis: Case Illustration and Literature Review by Kutoubi, Muhammad Aghiad, Dergham, Mohamad Yasser R., El Chediak, Alissar, Degheili, Jad A., Hallal, Ali H.

    Published in Case reports in radiology (01-01-2017)
    “…Pancreaticoduodenal artery aneurysms (PDA) are rare visceral aneurysms. Celiac trunk stenosis represents a common attributable aetiology for those aneurysms…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A2/A2B to B kidney transplantation outcomes: A single center 7-year experience by El Chediak, Alissar, Shawar, Saed, Fallahzadeh, Mohammad K, Forbes, Rachel, Schaefer, Heidi M, Feurer, Irene D, Rega, Scott, Triozzi, Jefferson L, Shaffer, David

    Published in Clinical transplantation (01-04-2024)
    “…Data on long-term outcomes following A2/A2B to B kidney transplants since the 2014 kidney allocation system (KAS) changes are few. The primary aim of this…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Optimizing tumor immune response through combination of radiation and immunotherapy by El Chediak, Alissar, Shamseddine, Ali, Bodgi, Larry, Obeid, Jean-Pierre, Geara, Fady, Zeidan, Youssef H.

    “…Radiation therapy and immunotherapy are two highly evolving modalities for the treatment of solid tumors. Immunotherapeutic drugs can either stimulate the…”
    Get full text
    Journal Article
  17. 17
  18. 18